Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.

by Ester Vilaprinyo, Carles Forné, Misericordia Carles, Maria Sala, Roger Pla, Xavier Castells, Laia Domingo, Montserrat Rue, Interval Cancer (INCA) Study Group
Published 2014-01-01